openPR Logo
Press release

Infectious Disease Therapeutics Market to Reach US$ 1,67,883.93 million by 2030

04-03-2024 08:55 AM CET | Health & Medicine

Press release from: The Insight Partners

Infectious Disease Therapeutics Market

Infectious Disease Therapeutics Market

The infectious disease therapeutics market size was valued US$ 1,19,708.77 million in 2022 and is expected to reach US$ 1,67,883.93 million by 2030; the market is estimated to record a CAGR of 4.30% during 2022-2030.

Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00016883?utm_source=OpenPR&utm_medium=10379

Key Players Analysis:
Pfizer Inc
Gilead Sciences Inc
F. Hoffmann-La Roche Ltd
Shionogi & Co Ltd
Bayer AG
BioCryst Pharmaceuticals Inc
GSK Plc
AbbVie Inc
Merck & Co Inc
Astellas Pharma Inc

The report covers key developments in the Infectious Disease Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Infectious Disease Therapeutics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Infectious Disease Therapeutics Market in the global market. Below mentioned is the list of few companies engaged in the Infectious Disease Therapeutics Market.

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behaviour & the growth of the market as well as industries.

MARKET SEGMENTATION
The infectious disease therapeutics market, by drug class, is segmented into anti-viral, anti-bacterial, anti-fungal, and others. The anti-viral segment held the largest share of the market in 2022; the anti-bacterial segment is projected to register the highest CAGR in the market during 2022-2030.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Infectious Disease Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2022 to 2030 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Infectious Disease Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.      

Get a Full Report Copy @ https://www.theinsightpartners.com/buy/TIPRE00016883?utm_source=OpenPR&utm_medium=10379

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Infectious Disease Therapeutics, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Disease Therapeutics Market to Reach US$ 1,67,883.93 million by 2030 here

News-ID: 3450133 • Views:

More Releases from The Insight Partners

Packaged Breadsticks Market Set for Strong Growth Driven by Rising Snacking Trends and Innovative Product Launches
Packaged Breadsticks Market Set for Strong Growth Driven by Rising Snacking Tren …
New York , US - {5 December 2025} - The global Packaged Breadsticks Market is poised to experience robust growth over the forecast period, supported by increasing consumer demand for convenient snacking options, product diversification, and expanding retail distribution channels. Breadsticks, once perceived as an accompaniment to meals, have now emerged as a popular standalone snack due to their crisp texture, versatile flavors, and longer shelf life. Manufacturers are capitalizing
Global Farming-as-a-Service (FaaS) Market to Experience Robust Growth Driven by Digital Agriculture, Mechanization & Sustainability Trends
Global Farming-as-a-Service (FaaS) Market to Experience Robust Growth Driven by …
New York , US - {5 December 2025} -The global Farming-as-a-Service (FaaS) Market is witnessing a significant surge in demand as the agriculture sector rapidly adopts advanced technologies to enhance farm productivity, reduce operational costs, and enable data-driven decision-making. With rising global food demand, increasing labor shortages, and the urgent need to improve farming efficiency, FaaS has emerged as a transformative service model reshaping the future of agriculture. The market
Compressor Lubricants Market Analysis by Business Methodologies, Financial Overview and Growth Prospects Predicted by 2031
Compressor Lubricants Market Analysis by Business Methodologies, Financial Overv …
The latest Compressor Lubricants Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Compressor Lubricants
Composite Doors and Windows Market Forecast to 2031 by Systematic Growth Analysis, Impressive Trending Strategies and Application by Key Players
Composite Doors and Windows Market Forecast to 2031 by Systematic Growth Analysi …
The Insight Partners delivers well-researched industry-wide information on the Composite Doors and Windows market. It provides information on the market's essential aspects such as top participants, factors driving Composite Doors and Windows Market growth, precise estimation of the Composite Doors and Windows Market size, upcoming trends, changes in consumer behavioral pattern, market's competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the

All 5 Releases


More Releases for Infectious

Infectious Disease Therapeutics Market - Infectious Disease Solutions: Revolutio …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Infectious Disease Therapeutics Market. Infectious Disease Therapeutics Market: https://www.growthplusreports.com/report/infectious-disease-therapeutics-market/9210 The Infectious Disease Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Infectious Disease Diagnostics Market Owing to the Increasing Prevalence of Infe …
According to Precision Business Insights (PBI) latest report, the infectious disease diagnostics market is expected to be worth USD 34,599.0 million in 2022, growing at a 6.4% CAGR from 2022 to 2028. Global Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments and Software & Services), By Type of Testing (Laboratory Testing and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays
Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) …
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease. Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/63 The U.S. FDA (United States Food and Drug Administration) is
Infectious Disease Diagnostics Market Entry Strategies, Countermeasures, Economi …
Market Expertz has published its latest research study titled 'Global Infectious Disease Diagnostics Market Report Forecast to 2027' gives a detailed assessment of the industry to offer vital information by evaluating the prevalent trends observed in the sector. The report includes valuable market insights provided by the industry experts by way of surveys and interviews as part of primary research. The authors of the study also undertake secondary research, which
Infectious Disease Diagnostics Market
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased